290
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Characterization of titanium dioxide nanoparticles modified with polyacrylic acid and H2O2 for use as a novel radiosensitizer

, , , , , , & show all
Pages 1319-1328 | Received 13 Apr 2016, Accepted 23 Sep 2016, Published online: 25 Oct 2016

References

  • Barnett GC, West CML, Dunning AM, Burnet NG, Europe PMC Funders Group. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 2009;9:134–142.
  • Baskar R. Cancer and radiation therapy: current advances and future directions. Int J Med Sci 2012;9:193–199.
  • Emami B. Tolerance of normal tissue to therapeutic radiation. Reports Radiother Oncol 2013;1:36–48.
  • Rockwell S, Dobrucki IT, Kim EY, Marrison ST, Vu VT. Hypoxia and radiation therapy: past history, ongoing research, and future promise. Curr Mol Med 2009;9:442–458.
  • Harrison LB, Chadha M, Hill R, Hu K, Shasha D. Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes. Oncologist. 2002;7:492–508.
  • Briggs B, Ververis K, Rodd AL, Foong LJ, Silva FM, Karagiannis TC. Photosensitization by iodinated DNA minor groove binding ligands: evaluation of DNA double-strand break induction and repair. J Photochem Photobiol B Biol 2011;103:145–152.
  • Song T, Zhang X, Fang M, Wu S. Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer. Onco Targets Ther 2015;3087–3094.
  • Niyazi M, Harter PN, Hattingen E, Rottler M, Baumgarten V, Proescholdt M, et al. Bevacizumab and radiotherapy for the treatment glioblastoma: brothers in arms or unholy alliance? Oncotarget 2016;7:2313–2328.
  • Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. Jama 1999;281:1623–1627.
  • Maggiorella L, Barouch G, Devaux C, Pottier A, Deutsch E, Bourhis J, et al. Nanoscale radiotherapy with hafnium oxide nanoparticles. Future Oncol 2012;8:1167–1181.
  • Jain S, Ch B, Coulter JA, Ph D, Hounsell AR, Karl T, Europe PMC Funders Group. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radiat Oncol Biol Phys. 2011;79:531–539.
  • Kohshi K, Kinoshita Y, Imada H, Kunugita N, Abe H, Terashima H, et al. Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas. Br J Cancer 1999;80:236–241.
  • Yang Y, Jin C, Li H, He Y, Liu Z, Bai L, Dou K. Improved radiosensitizing effect of the combination of etanidazole and paclitaxel for hepatocellular carcinoma in vivo. Exp Ther Med 2012;3:299–303.
  • Bussink J. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide. Acta Oncol (Madr) 1999;38:875–882.
  • Hehlgans S, Oppermann J, Reichert S, Fulda S, Rödel C, Rödel F. The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis. Radiat Oncol 2015;10:198.
  • Cheng J, Liu W, Zeng X, Zhang B, Guo Y, Qiu M, et al. XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma. Cancer Sci 2015;106:1678–1686.
  • Schilling D, Kühnel A, Konrad S, Tetzlaff F, Bayer C, Yaglom J, Multhoff G. Sensitizing tumor cells to radiation by targeting the heat shock response. Cancer Lett 2015;360:294–301.
  • He S, Smith DL, Sequeira M, Sang J, Bates RC, Proia DA. The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer. Invest New Drugs 2014;32:577–586.
  • Lamb R, Fiorillo M, Chadwick A, Ozsvari B, Reeves KJ, Smith DL, et al. Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: implications for more effective radiation therapy. Oncotarget 2015;6(16):14005–14025.
  • Parrales A, Iwakuma T. Targeting oncogenic mutant p53 for Cancer Therapy. Front Oncol 2015;5:1–13.
  • Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology 2014;3:e955691.
  • Matsui K, Karasaki M, Segawa M, Hwang SY, Tanaka T, Ogino C, Kondo A. Biofunctional TiO2 nanoparticle-mediated photokilling of cancer cells using UV irradiation. Medchemcomm 2010;1:209–211.
  • Fujishima A, Honda K. Electrochemical photolysis of water at a semiconductor electrode. Nature 1972;238:37–38.
  • Nakayama M, Sasaki R, Ogino C, Tanaka T, Morita K, Umetsu M, et al. Titanium peroxide nanoparticles enhanced cytotoxic effects of X-ray irradiation against pancreatic cancer model through reactive oxygen species generation in vitro and in vivo. Radiat Oncol 2016;11:91.
  • Boonstra AH, Mutsaers CAHA. Adsorption of hydrogen peroxide on the surface of titanium dioxide. J Phys Chem 1975;79:1940–1943.
  • Lee MC, Yoshino F, Shoji H, Takahashi S, Todoki K, Shimada S, Kuse-Barouch K. Characterization by electron spin resonance spectroscopy of reactive oxygen species generated by titanium dioxide. J Dent Res 2005;84:178–182.
  • Etacheri V, Seery MK, Hinder SJ, Pillai SC. Oxygen rich titania: a dopant free, high temperature stable, and visible-light active anatase photocatalyst. Adv Funct Mater 2011;21:3744–3752.
  • Doong R, Chang W. Photoassisted titanium dioxide mediated degradation of organophosphorus pesticides by hydrogen peroxide. J Photochem Photobiol A Chem 1997;107:239–244.
  • Doong RA, Chang WH. Photodegradation of parathion in aqueous titanium dioxide and zero valent iron solutions in the presence of hydrogen peroxide. J Photochem Photobiol A Chem 1998;116:221–228.
  • Zou J, Gao J, Wang Y. Synthesis of highly active H2O2-sensitized sulfated titania nanoparticles with a response to visible light. J Photochem Photobiol A Chem 2009;202:128–135.
  • Wong CC, Chu W. The hydrogen peroxide-assisted photocatalytic degradation of alachlor in TiO suspensions the hydrogen peroxide-assisted photocatalytic degradation of alachlor in TiO2 suspensions. Environ Sci Technol 2003;37:2310–2316.
  • Ogino C, Dadjour MF, Iida Y, Shimizu N. Decolorization of methylene blue in aqueous suspensions of titanium peroxide. J Hazard Mater 2008;153:551–556.
  • Sánchez LD, Taxt-Lamolle SFM, Hole EO, Krivokapić A, Sagstuen E, Haugen HJ. TiO2 suspension exposed to H2O2 in ambient light or darkness: degradation of methylene blue and EPR evidence for radical oxygen species. Appl Catal B Environ 2013;142–143:662–667.
  • Harbour JR, Tromp J, Hair ML. Photogeneration of hydrogen peroxide in aqueous TiO2 dispersions. Can J Chem 1985;63:204–208.
  • Tengvall P, Lundström I, Sjöqvist L, Elwing H, Bjursten LM. Titanium-hydrogen peroxide interaction: model studies of the influence of the inflammatory response on titanium implants. Biomaterials 1989;10:166–175.
  • Ogawa Y, Ue H, Tsuzuki K, Tadokoro M, Miyatake K, Sasaki T, et al. New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms. Oncol Rep 2008;19:1389–1394.
  • Ogawa Y, Kubota K, Ue H, Tadokoro M, Matsui R, Yamanishi T, et al. Safety and effectiveness of a new enzyme-targeting radiosensitization treatment (KORTUC II) for intratumoral injection for low-LET radioresistant tumors. Int J Oncol 2011;39:553–560.
  • Ogawa Y. Paradigm shift in radiation biology/radiation oncology – exploitation of the “H2O2 effect” for radiotherapy using low-let (linear energy transfer) radiation such as X-rays and high-energy electrons. Cancers (Basel) 2016;8:1–12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.